HT5-13928-25578 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-24
Dose 1 — Moderna
2021-01-21
Registered in v-safe
2021-01-21
Dose 2 — Moderna
2021-01-22
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Fatigue or tiredness

Adult check-in
2021-01-23
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Joint pains, Fatigue or tiredness

Adult check-in
2021-01-24
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-07-22
Survey response — 6 months, dose 2
MedDRA: Viral upper respiratory tract infection — Feeling: Good · Be unable to do your normal daily activities

Free text: A moderate viral upper respiratory illness

MedDRA releases: 2024-11 · check-in free text available
2021-11-22
Dose 3 — Pfizer-BioNTech
2022-01-21
Survey response — 12 months, dose 2
MedDRA: COVID-19, Pregnancy — Feeling: Fair · Be unable to work or attend school

Free text: Pregnancy, COVID-19

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-24	Moderna
2	2021-01-21	Moderna
3	2021-11-22	Pfizer-BioNTech	No

Free text

Release 9 — 6 months, dose 2

2021-07-22

Symptoms: A moderate viral upper respiratory illness

Release 11 — 12 months, dose 2

2022-01-21

Symptoms: Pregnancy, COVID-19

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Pregnancy	·	·	✓
SD	Viral upper respiratory tract infection	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release